Searched for: in-biosketch:yes
person:mcdonm03
EXCIMER-LASER HYPEROPIA PRK PHASE-I - THE BLIND EYE STUDY [Meeting Abstract]
MCDONALD, MB; TELFAIR, WB; NESBURN, AB; SALZ, JJ; MACY, JI; PENDER, PM; KEARNEY, WF; PENDLETON, KM; KLYCE, SD; VARNELL, RJ
ISI:A1994MZ58501074
ISSN: 0146-0404
CID: 105851
EFFECT OF DECENTRATION OF THE ABLATION ON CONTRAST SENSITIVITY AFTER EXCIMER PHOTOREFRACTIVE KERATECTOMY FOR MILD-TO-MODERATE MYOPIA [Meeting Abstract]
MORENO, ML; MCDONALD, MB; RIBEIRO, J; KLYCE, SD; SMOLEK, M
ISI:A1994MZ58504107
ISSN: 0146-0404
CID: 105852
A COMPARATIVE IN-VIVO STUDY OF 2 VEHICLES FOR DELIVERY OF EPIDERMAL GROWTH-FACTOR TO THE WOUNDED RABBIT CORNEA [Meeting Abstract]
PENDLETON, KM; VARNELL, ED; BEUERMAN, RW; KAUFMAN, HE; THOMPSON, HW; MCDONALD, MB; NGUYEN, D
ISI:A1994MZ58504324
ISSN: 0146-0404
CID: 105853
A COMPARISON OF CLINICAL-RESULTS OF PHOTOREFRACTIVE KERATECTOMY FOR MILD-TO-MODERATE MYOPIA WITH THE VISX AND SUMMIT EXCIMER LASERS - A RETROSPECTIVE STUDY [Meeting Abstract]
RIBEIRO, JC; ANCEL, JM; MCDONALD, MB; BOKOBZA, Y; VARNELL, RJ
ISI:A1994MZ58503516
ISSN: 0146-0404
CID: 105854
PUPILLARY BLOCK DURING CATARACT-SURGERY [Letter]
UPDEGRAFF, SA; PEYMAN, GA; MCDONALD, MB
ISI:A1994PA91000030
ISSN: 0002-9394
CID: 105855
PUPILLARY BLOCK DURING CATARACT-SURGERY - REPLY [Letter]
UPDEGRAFF, SA; PEYMAN, GA; MCDONALD, MB
ISI:A1994PQ07700023
ISSN: 0002-9394
CID: 105856
Fixation of conjunctival autografts with an organic tissue adhesive [Letter]
Cohen, R A; McDonald, M B
PMID: 8363455
ISSN: 0003-9950
CID: 105747
Traumatic corneal abrasions after excimer laser keratectomy [Letter]
Vrabec, M P; McDonald, M B; Chase, D S; Aitken, P A; Varnell, R J
PMID: 8328526
ISSN: 0002-9394
CID: 105748
Effects of scleral reinforcement on the elongation of growing cat eyes
Jacob-LaBarre, J T; Assouline, M; Conway, M D; Thompson, H W; McDonald, M B
OBJECTIVE: We investigated the effect of scleral reinforcement on ocular elongation in the rapidly growing eyes of juvenile cats. METHODS: Bands made from donor sclera or expanded polytetrafluoroethylene were used to reinforce one eye of each animal; contralateral eyes underwent sham surgery. RESULTS: During 5 months of follow-up, normal intraocular pressures implied normal functioning of angle structures. A-scan on the central axis showed no difference in globe lengths. Direct physical measurements of the posterior aspect of the globe at enucleation revealed significant decreases in off-center lengthening where reinforcement was present compared with unreinforced areas in the same eyes and in the contralateral unbanded eyes. Venous beading in fundus photographs of three eyes suggested impairment of venous outflow. CONCLUSIONS: Scleral reinforcement appears to control expansion of the growing cat eye to a limited extent, but the effects on vision and retinal perfusion require further investigation
PMID: 8328941
ISSN: 0003-9950
CID: 105749
Topical bupivacaine and proparacaine: a comparison of toxicity, onset of action, and duration of action
Liu, J C; Steinemann, T L; McDonald, M B; Thompson, H W; Beuerman, R W
Bupivacaine is a local ocular anesthetic with a long duration of action when administered by retrobulbar injection. To determine the potential for the use of bupivacaine as a topical ocular anesthetic, the onset and duration of action and toxicity of various concentrations of bupivacaine were studied after instillation in rabbit eyes. The onset and duration of action were not significantly different from that of topical 0.5% proparacaine. Increasing the pH of the bupivacaine solution from 5.7 to 6.5 nearly doubled the duration of action, but the increase was not sufficient to be clinically important. Slit lamp biomicroscopic examination and scanning electron microscopy showed that bupivacaine was less toxic to the corneal epithelium than 0.5% proparacaine. Healing after keratectomy was significantly more rapid in eyes treated with 0.75% bupivacaine, compared with eyes treated with 0.5% proparacaine. These results suggest that bupivacaine may be less toxic to the corneal epithelium than proparacaine and could be clinically useful for topical ocular anesthesia, particularly if pharmacologic modifications can increase the duration of anesthesia provided by this drug
PMID: 8500336
ISSN: 0277-3740
CID: 105750